Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia

Neuroscience

Volumn 93, Issue 3, 1999, Pages 843-853

  Bordelon, Y M ^a   Chesselet, M F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Enkephalin; Excitotoxicity; Huntington's disease; Rat; Striatum; Substance P

Indexed keywords

ENKEPHALIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROPEPTIDE; QUINOLINIC ACID; SUBSTANCE P;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; EFFERENT NERVE; GLOBUS PALLIDUS; HUNTINGTON CHOREA; IMMUNOREACTIVITY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BASAL GANGLIA; CORPUS STRIATUM; CYTOSKELETON; DISEASE MODELS, ANIMAL; DNA DAMAGE; EFFERENT PATHWAYS; ENKEPHALINS; EXCITATORY AMINO ACID AGONISTS; GLOBUS PALLIDUS; HUNTINGTON DISEASE; INJECTIONS; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURONS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SUBSTANCE P;

EID: 0032815531     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00239-0     Document Type: Article

References (58)

1. Albin R.L., Qin Y., Young A.B., Penney J.B., Chesselet M.-F. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Ann. Neurol. 30:1991;542-549.
2. Albin R.L., Reiner A., Anderson K.D., Dure L.S., Handelin B., Balfour R., Whetsell W.O., Penney J.B., Young A.B. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31:1992;425-430.
3. Albin R.L., Reiner A., Anderson K.D., Penney J.B., Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27:1990;357-365.
4. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., Markel D.S., Tourtellotte W.W., Reiner A. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. New Engl. J. Med. 322:1990;1293-1298.
5. Augood S.J., Faull R.L.M., Love D.R., Emson P.C. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience. 72:1996;1023-1036.
6. Ballough G.P.H., Martin L.J., Cann F.J., Graham J.S., Smith C.D., Kling C.E., Forster J.S., Phann S., Filbert M.G. Microtubule-associated protein 2 (MAP-2): a sensitive marker of seizure-related brain damage. J. Neurosci. Meth. 61:1995;23-32.
7. Bazzett T.J., Becker J.B., Kaatz K.W., Albin R.L. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration. Expl Neurol. 120:1993;177-185.
8. Beal M.F., Ferrante R.J., Swartz K.J., Kowall N.W. Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci. 11:1991;1649-1659.
9. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
10. Bernhardt R., Matus A. Light and electron microscopic studies of the distribution of microtubule-associated protein 2 in rat brain: a difference between dendritic and axonal cytoskeleton. J. comp. Neurol. 226:1984;203-221.
11. Binder L.I., Frankfurter A., Rebhun L.I. Differential localization of MAP-2 and tau neurons in situ. Ann. N. Y. Acad. Sci. 466:1986;145-166.
12. Bordelon Y., Chesselet M.-F. Selective vulnerability of striatal neurons of the matrix compartment to quinolinic acid-induced DNA damage. Soc. Neurosci. Abstr. 23:1997;188.
13. Bordelon Y.M., Chesselet M.-F., Erecinska M, Silver I.A. Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience. 83:1998;459-469.
14. Bordelon Y.M., Chesselet M.-F., Nelson D., Welsh F., Erecinska M. Energetic dysfunction in quinolinic acid lesioned rat striatum. J. Neurochem. 69:1997;1629-1639.
15. Bordelon Y. M., McKenzie L. and Chesselet M.-F. (1999) Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injection into rat striatum. J. comp. Neurol. (in press).
16. Chesselet M.-F. (1996) Quantitative analysis and interpretation of data for in situ hybridization at the cellular level. In In Situ Hybridization Techniques for the Brain (ed. Henderson Z.), pp. 141-149. Wiley and Sons, New York.
17. Chesselet M.-F., Robbins E. Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of pre-protachykinin mRNA. Neurosci. Lett. 96:1989;47-53.
18. Chesselet M.-F., Weiss L.T., Wuenschell C., Tobin A.J., Affolter H.U. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. J. comp. Neurol. 262:1987;125-140.
19. Choi D.W. Calcium and excitotoxic neuronal injury. Ann. N. Y. Acad. Sci. 747:1994;162-171.
20. Dawbarn D., De Quidt M.E., Emson P.C. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res. 340:1985;251-260.
21. Dure L.S., Wiess S., Standaert D.G., Rudolf G., Testa C.M., Young A.B. DNA fragmentation and immediate early gene expression in rat striatum following quinolinic acid administration. Expl Neurol. 133:1995;207-214.
22. Felipo V., Grau E., Miñana M.-D., Grisolía S. Ammonium injection induces an N-methyl-D-aspartate receptor-mediated proteolysis of the microtubule-associated protein MAP-2. J. Neurochem. 60:1993;1626-1630.
23. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
24. Ferrante R.J., Kowall N.W., Richardson E.P., Bird E.D., Martin J.B. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci. Lett. 71:1986;283-288.
25. Figueredo-Cardenas G., Anderson K.D., Chen Q., Veenman C.L., Reiner A. Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats. Expl Neurol. 129:1994;37-56.
26. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
27. 2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid. Expl Neurol. 121:1993;261-269.
28. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
29. Haber S., Elde R. The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study. Neuroscience. 7:1982;1049-1095.
30. Hoover B.R., Schuller J.J., Marshall J.F. Globus pallidus neurons that express enkephalin: population characteristics and regulation of mRNA by nigrostriatal injury. Soc. Neurosci. Abstr. 24:1998;412.
31. Huber G., Matus A. Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. J. Neurosci. 4:1984;151-160.
32. Hughes P.E., Alexi T., Yoshida T., Schreiber S.S., Knusel B. Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience. 74:1996;1143-1160.
33. Kitagawa K., Matsumoto M., Niinobe M., Mikoshiba K., Hata R., Ueda H., Handa N., Fununaga R., Isaka Y., Kimura K., Kamada T. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage - immunohistochemical investigation of dendritic damage. Neuroscience. 31:1989;401-411.
34. Kowall N.W., Ferrante R.J., Martin J.B. Patterns of loss in Huntington's disease. Trends Neurosci. 10:1987;24-29.
35. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. natn. Acad. Sci. U.S.A. 84:1987;881-885.
36. Krekoski C.A., Parhad I.M., Clark A.W. Attenuation and recovery of nerve growth factor receptor mRNA in dorsal root ganglion neurons following axotomy. J. Neurosci. Res. 43:1996;1-11.
37. Levine M.S., Chesselet M.-F., Koppel A., Gruen E., Cepeda C., Carpenter E.M., Zanjani H., Hurst R.S., Altemus K.L., Murai J.S., Efstratiadis A., Zeitlin S. Enhanced sensitivity to glutamate receptor activation in mouse models of Huntington's disease. Soc. Neurosci. Abstr. 24:1998;972.
38. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurological disorders. New Engl. J. Med. 330:1994;613-622.
39. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1997;493-506.
40. Meldrum B.S. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. 3:1993;405-412.
41. Murphy D.B., Borisy G.G. Association of high-molecular-weight proteins with microtubules and their role in microtubule assembly in vitro. Proc. natn. Acad. Sci. U.S.A. 72:1975;2696-2700.
42. Olney J.W., Ho O.L., Rhee V. Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Expl Brain Res. 14:1971;61-76.
43. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
44. Portera-Cailliau C., Hedreen J.C., Price D.L., Koliatsos V.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
45. Qin Y., Soghomonian J.-J., Chesselet M.-F. Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats. Expl Neurol. 115:1992;200-211.
46. Qin Z.-H., Wang Y., Chase T.N. Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain. Brain Res. 725:1996;166-176.
47. Raley-Sussman K.M., Murata J. Time course of protein changes following in vitro ischemia in the rat hippocampal slice. Brain Res. 694:1995;94-102.
48. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington disease. Proc. natn. Acad. Sci. U.S.A. 85:1988;5733-5737.
49. Richfield E.K., Maguire-Zeiss K.A., Cox C., Gilmore J., Voorn P. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients. Ann. Neurol. 37:1995;335-343.
50. Roberts R.C., Ahn A., Swartz K.J., Beal M.F., DiFiglia M. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Expl Neurol. 124:1993;272-282.
51. Sapp E., Ge P., Aizawa H., Bird E., Penney J., Young A.B., Vonsattel J.P., DiFiglia M. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience. 64:1995;397-404.
52. Schwarcz R., Whetsell W.O., Mangano R.M. Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-318.
53. Tessler A., Himes B.T., Krieger N.R., Murray M., Goldberger M.E. Sciatic nerve transection produces death of dorsal root ganglion cells and reversible loss of substance P in spinal cord. Brain Res. 332:1985;209-218.
54. Wang J.Q., Daunais J.B., McGinty J.F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353.
55. Whetsell W.O. Current concepts of excitotoxicity. J. Neuropath. exp. Neurol. 55:1996;1-13.
56. White J.K., Auerbach W., Duyao M.P., Vonsattel J.P., Gusella J.F., Joyner A.L., MacDonald M.E. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17:1997;404-410.
57. Wong J., Oblinger M.M. Changes in neurofilament gene expression occur after axotomy of dorsal root ganglion neurons: an in situ hybridization study. Metabol. Brain Dis. 2:1987;291-303.
58. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. J. biol. Chem. 259:1984;14,301-14,308.